Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 42,70
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: preigu, Osnabrück, Germania
EUR 38,70
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Enhancing Irbesartan Bioavailability via Solid Dispersion | Optimizing Dissolution of Irbesartan Through Advanced Solid Dispersion Techniques | Rashmitha Vallala (u. a.) | Taschenbuch | Englisch | 2024 | LAP LAMBERT Academic Publishing | EAN 9786208119713 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 44,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: Majestic Books, Hounslow, Regno Unito
EUR 59,59
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 43,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 61,06
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 43,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like ß-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ß-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ß-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ß-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 44,59
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan¿s solubility through solid dispersions using carriers like ¿-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ¿-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug¿s transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ¿-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ¿-cyclodextrin in solid dispersions effectively enhances Irbesartan¿s solubility and therapeutic potential in treating hypertension.